DAYTON, Ohio and CINCINNATI, Aug. 16, 2016 – Brixey & Meyer Capital (“BMC”) announced today it has held its final closing of the BMC Growth Fund, LLC.  This final closing held on July 18, 2016 resulted in total commitments of approximately $18.0 million.  The fund’s investors are made up of successful entrepreneurs and private investors predominately from Southwest Ohio.

The fund was launched in November 2015 in conjunction with the first acquisition of the fund, Clinical Research Solutions.  Clinical Research Solutions (“CRS”) is headquartered in Cleveland, Ohio with locations throughout Ohio and Tennessee.  CRS performs phase I to IV clinical trials for large and small pharmaceutical companies across the world.

Read more